SG11202000893QA - Use of inhaled nitric oxide for the treatment of pulmonary hypertension associated with lung disease - Google Patents

Use of inhaled nitric oxide for the treatment of pulmonary hypertension associated with lung disease

Info

Publication number
SG11202000893QA
SG11202000893QA SG11202000893QA SG11202000893QA SG11202000893QA SG 11202000893Q A SG11202000893Q A SG 11202000893QA SG 11202000893Q A SG11202000893Q A SG 11202000893QA SG 11202000893Q A SG11202000893Q A SG 11202000893QA SG 11202000893Q A SG11202000893Q A SG 11202000893QA
Authority
SG
Singapore
Prior art keywords
treatment
nitric oxide
lung disease
pulmonary hypertension
hypertension associated
Prior art date
Application number
SG11202000893QA
Other languages
English (en)
Inventor
Deborah Quinn
Parag Shah
Original Assignee
Bellerophon Pulse Tech Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bellerophon Pulse Tech Llc filed Critical Bellerophon Pulse Tech Llc
Publication of SG11202000893QA publication Critical patent/SG11202000893QA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/021—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes operated by electrical means
    • A61M16/022—Control means therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/10—Preparation of respiratory gases or vapours
    • A61M16/12—Preparation of respiratory gases or vapours by mixing different gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A61M2016/0027—Accessories therefor, e.g. sensors, vibrators, negative pressure pressure meter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A61M2016/003—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter
    • A61M2016/0033—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter electrical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/02—Gases
    • A61M2202/0208—Oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/02—Gases
    • A61M2202/0266—Nitrogen (N)
    • A61M2202/0275—Nitric oxide [NO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/10—Trunk
    • A61M2210/1025—Respiratory system
    • A61M2210/1039—Lungs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/12—Blood circulatory system
    • A61M2210/125—Heart
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/30—Blood pressure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/40—Respiratory characteristics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SG11202000893QA 2017-08-30 2018-08-29 Use of inhaled nitric oxide for the treatment of pulmonary hypertension associated with lung disease SG11202000893QA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762552022P 2017-08-30 2017-08-30
US201762611325P 2017-12-28 2017-12-28
PCT/US2018/048526 WO2019046415A1 (en) 2017-08-30 2018-08-29 USE OF INHALED NITRIC OXIDE FOR THE TREATMENT OF PULMONARY HYPERTENSION ASSOCIATED WITH PULMONARY DISEASE

Publications (1)

Publication Number Publication Date
SG11202000893QA true SG11202000893QA (en) 2020-02-27

Family

ID=65526008

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202000893QA SG11202000893QA (en) 2017-08-30 2018-08-29 Use of inhaled nitric oxide for the treatment of pulmonary hypertension associated with lung disease

Country Status (14)

Country Link
US (2) US20200360647A1 (enExample)
EP (2) EP3675719A4 (enExample)
JP (4) JP2020532531A (enExample)
KR (1) KR20200083443A (enExample)
CN (3) CN120131593A (enExample)
AU (2) AU2018324004A1 (enExample)
BR (1) BR112020004205A2 (enExample)
CA (4) CA3266267A1 (enExample)
IL (2) IL272308A (enExample)
MX (2) MX2020002194A (enExample)
PH (1) PH12020500197A1 (enExample)
SG (1) SG11202000893QA (enExample)
TW (3) TWI887195B (enExample)
WO (2) WO2019046415A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113456966A (zh) 2017-02-27 2021-10-01 第三极股份有限公司 用于移动生成一氧化氮的系统和方法
KR102354762B1 (ko) 2017-02-27 2022-01-25 써드 폴, 아이엔씨. 산화 질소 발생 시스템 및 방법
MX2020010523A (es) 2017-02-27 2021-02-09 Third Pole Inc Sistemas y metodos para generar oxido nitrico.
JP2022517788A (ja) * 2019-01-14 2022-03-10 ベレロフォン・セラピューティクス Ｐｄｅ－５阻害剤と吸入用一酸化窒素との併用薬物療法
EP3969415A4 (en) 2019-05-15 2023-08-16 Third Pole, Inc. ELECTRODES FOR NITRIC OXIDE GENERATION
CN114375284A (zh) 2019-05-15 2022-04-19 第三极股份有限公司 用于生成一氧化氮的系统和方法
CN115151183A (zh) 2020-01-11 2022-10-04 第三极股份有限公司 具有湿度控制的用于一氧化氮生成的系统和方法
US12239460B2 (en) 2020-05-06 2025-03-04 Janssen Pharmaceuticals, Inc. Controlling operation of drug administration devices using surgical hubs
CN116096446A (zh) * 2020-05-29 2023-05-09 背勒丰治疗公司 脉冲递送气态药物的方法
US20210395905A1 (en) 2020-06-18 2021-12-23 Third Pole, Inc. Systems and methods for preventing and treating infections with nitric oxide
EP4405019A4 (en) 2021-09-23 2025-07-16 Third Pole Inc SYSTEMS AND METHODS FOR PROVIDING NITRIC OXIDE

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007333115B2 (en) * 2006-12-12 2013-01-10 Gilead Sciences, Inc. Composition for treating a pulmonary hypertension
US7943667B2 (en) * 2007-10-11 2011-05-17 Duke University Potentiating the effect of compound comprising nitric oxide
HUE043235T2 (hu) * 2008-01-31 2019-08-28 Univ Vanderbilt Terápiás kezelések tüdõbetegségekhez
CA2671029A1 (en) * 2009-06-30 2010-12-30 James S. Baldassarre Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension
US20120093948A1 (en) * 2009-11-20 2012-04-19 Fine David H Nitric Oxide Treatments
WO2012075420A1 (en) * 2010-12-03 2012-06-07 Geno Llc Nitric oxide treatments
MX377688B (es) * 2012-05-31 2025-03-10 Mallinckrodt Hospital Products Ip Ltd Métodos para administrar óxido nítrico a la sangre arterial o arterializada.
US9795756B2 (en) * 2012-12-04 2017-10-24 Mallinckrodt Hospital Products IP Limited Cannula for minimizing dilution of dosing during nitric oxide delivery
IL277164B2 (en) * 2012-12-04 2023-12-01 Mallinckrodt Hospital Products Ip Ltd A system for providing oxygenated nitrogen
CA2936490C (en) * 2014-01-10 2022-10-04 Ino Therapeutics Llc Methods of using inhaled nitric oxide gas for treatment of acute respiratory distress syndrome in children
CN106572813B (zh) * 2014-03-28 2020-07-17 沙普医疗系统公司 用于量化慢性疾病的多种可能形式对被报告呼吸困难的患者的贡献的可能性的模式识别系统
EP3386574A4 (en) * 2015-12-11 2019-07-17 Vero Biotech LLC METHOD AND APPARATUS FOR GAS ADMINISTRATION COMPRISING NITRIC OXIDE FOR TREATING FIBROSIS
US20170182088A1 (en) * 2015-12-28 2017-06-29 Geno Llc Method and apparatus for administering nitric oxide with supplemental drugs
EP3970730B1 (en) * 2016-02-12 2024-05-01 Mallinckrodt Pharmaceuticals Ireland Limited System for use and monitoring of inhaled nitric oxide with left ventricular assist devices

Also Published As

Publication number Publication date
WO2019046415A1 (en) 2019-03-07
JP2020532531A (ja) 2020-11-12
CN120131593A (zh) 2025-06-13
IL272314A (en) 2020-03-31
AU2018323547A1 (en) 2020-02-13
EP3675840A4 (en) 2021-05-12
US20200360647A1 (en) 2020-11-19
TW201912151A (zh) 2019-04-01
CA3266267A1 (en) 2025-04-28
JP2025029093A (ja) 2025-03-05
BR112020004205A2 (pt) 2020-09-01
CN111372577A (zh) 2020-07-03
WO2019046413A1 (en) 2019-03-07
IL272308A (en) 2020-03-31
AU2018324004A1 (en) 2020-02-13
JP2023100985A (ja) 2023-07-19
US20200188319A1 (en) 2020-06-18
CA3073948A1 (en) 2019-03-07
CA3266320A1 (en) 2025-05-31
MX2025004666A (es) 2025-05-02
TW201919590A (zh) 2019-06-01
CA3073949A1 (en) 2019-03-07
MX2020002194A (es) 2020-11-24
PH12020500197A1 (en) 2020-10-19
TW202416939A (zh) 2024-05-01
KR20200083443A (ko) 2020-07-08
JP2020532521A (ja) 2020-11-12
CN111315283A (zh) 2020-06-19
TWI887195B (zh) 2025-06-21
EP3675719A1 (en) 2020-07-08
EP3675719A4 (en) 2021-07-14
EP3675840A1 (en) 2020-07-08

Similar Documents

Publication Publication Date Title
SG11202000893QA (en) Use of inhaled nitric oxide for the treatment of pulmonary hypertension associated with lung disease
IL275683A (en) Administering pulses of inhaled nitrous oxide for the treatment of pulmonary hypertension
IL275678A (en) Using nitrous oxide and inhaled oxygen to treat pulmonary hypertension
IL256175A (en) Using exosomes to treat the disease
LT3496739T (lt) Kompozicijos ir būdai, skirti plaučių hipertenzijai gydyti
IL271117B (en) Diazabicyclic mutated imidazopyrimidines and their use in the treatment of respiratory disorders
GB201516558D0 (en) An inhalable composition and an inhaler
IL283469A (en) Inhalable preparations for use in the treatment of lung diseases
IL260154A (en) Multidose inhaler
HUE056471T2 (hu) Dalargin akut légzõszervi vírusos fertõzések kezelésében történõ alkalmazásra
GB201500314D0 (en) Pharmaceutical formulations for the treatment of pulmonary arterial hypertension
PL3329281T3 (pl) Nieinwazyjne wykrywanie nowotworu pochodzącego z tkanki poza płucem przy użyciu wydychanego powietrza
EP3104776A4 (en) Diagnosis and treatment of respiratory disorders
IL254142B (en) Tredifitant for use in the treatment of a disease or medical condition that responds to Tredifitent
EP3313260A4 (en) PEDIATRIC NOSE ENDOSCOPE, GASTROSCOPE AND AERODIGESTIVSKOP
IL280444A (en) Use of nitrous oxide is aimed at ameliorating severe hypoxemia
HUE037663T2 (hu) Kalcitonin mimetikumok betegségek és rendellenességek kezelésére
PL3307293T3 (pl) Preparaty do leczenia zaburzeń jamy ustnej, gardła i dróg oddechowych
AU2018290809A1 (en) Biomarkers for the diagnosis and treatment of fibrotic lung disease
PT3517155T (pt) Inalador acionado por respiração
LT3687567T (lt) Anti-adrenomedulino rišiklis, skirtas panaudoti taikant ligos simptomų terapiją arba profilaktiką
HUE050456T2 (hu) Dimetil-amino-mikeliolid tüdõfibrózis kezelésében történõ alkalmazásra
EP3703660A4 (en) Inhalation of nitric oxide
IL276792A (en) Inhaler and methods for using it
SG11201707789YA (en) A specific trifluoroethyl quinoline analogue for use in the treatment of sjögren's syndrome